CMS Transparency Rules: What Manufacturers Must Prepare For

The market access landscape is shifting. This time, the catalyst isn’t just pricing reform. It’s transparency. The Centers for Medicare & Medicaid Services (CMS) is expanding disclosure requirements around pricing, contracting, and value justification. What used...

Preparing for 2026: 5 Priorities for Market Access Leaders

2026 isn’t far off. Are your access priorities ready for the next wave of IRA-driven disruption? Between Inflation Reduction Act (IRA) implementation milestones, global pricing pressures, and payer adoption of new contracting models, the next 18 months will redefine...

Linked EMR + Claims Data for Stronger HEOR Evidence

Manufacturers know that evidence is currency in payer negotiations. Fragmented datasets only tell a partial story that leaves payers skeptical. That’s why linked datasets have become the gold standard for health economics and outcomes research (HEOR). EMRClaims+ from...

MAVA in Action: Launch Strategy Shifted in Just 5 Days

Launch plans rarely survive first contact with payers. One immunology manufacturer learned this firsthand. Their internal strategy had a clear value story, aligned teams, and a rebate framework they believed would secure access. Then they tested it with MAVA®. Launch...